203 results on '"Cohen-Cymberknoh M"'
Search Results
2. EPS9.01 Utilizing intestinal organoids to assess in-vitro responses to CFTR modulators in rare CFTR variants
3. P082 Optimizing CFTR modulator therapy management for cystic fibrosis through the ReX platform
4. WS06.05 Long-term outcomes in people with CF lacking early spirometry response to elexacaftor/tezacaftor/ivacaftor therapy
5. The Long-Term Effect of a Quality Improvement Intervention in the Management of Bronchiolitis
6. P077 Clinical and functional efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying the N1303K mutation
7. WS02.02 Ovarian reserve in women with cystic fibrosis: is this a cause of subfertility?
8. P073 Clinical efficacy of CFTR modulator therapy in patients carrying the I1234V mutation
9. 619 Antisense oligonucleotide splicing modulation as a novel cystic fibrosis therapeutic approach for the W1282X nonsense mutation
10. P044 Treatment benefits of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis carrying non-F508del mutations
11. P088 Ventilation inhomogeneity in patients with cystic fibrosis and pancreatic sufficiency and insufficiency
12. Changes in sleep in people with cystic fibrosis and primary ciliary dyskinesia over time and after CFTR modulator therapy
13. P179 Maternal and foetal outcomes of multigravida cystic fibrosis patients
14. P052 Efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with normal/near normal FEV1 (≥70%)
15. DIFFERENCES IN DISEASE EXPRESSION BETWEEN CF WITH PANCREATIC INSUFFICIENCY, PANCREATIC SUFFICIENCY AND PRIMARY CILIARY DYSKINESIA: 373
16. COMPARISON OF NASAL POTENTIAL DIFFERENCE AND INTESTINAL CURRENT MEASUREMENTS AS POTENTIAL THERAPEUTIC ENDPOINT MEASURES IN CYSTIC FIBROSIS: 217
17. The Long-Term Effect of a Quality Improvement Intervention in the Management of Bronchiolitis
18. Whole Exome Sequencing Accuracy in the Diagnosis of Primary Ciliary Dyskinesia
19. Normal First Expiratory Volume in One Second (FEV1) in Cystic Fibrosis Patients, How Normal Are the Lungs?
20. WS07-6 Clinical characteristics of patients with normal spirometry - not as normal as it would seem!
21. ePS2.02 Comparison of sleep disorders between patients with primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency
22. ePS2.01 Polysomnographic findings in cystic fibrosis: a meta-analysis
23. Is There a Role for Selected Bronchoscopy in Cystic Fibrosis?
24. P217 Cystic fibrosis with pancreatic insufficiency is associated with a high incidence of subfertility in women
25. P087 Monitoring amikacin pharmacokinetics for personal dose optimisation
26. WS19.4 Glucose and insulin area under the curve (AUC) can differentiate between cystic fibrosis patients that may benefit from early insulin treatment
27. EPS6.04 Correlation between six-minutes-walk-test and cystic fibrosis disease severity
28. 26 Nasal potential difference in young children is feasible
29. EPS2.6 Prevalence and characteristics of attention deficit hyperactivity disorder in patients with cystic fibrosis
30. 67 Effect Size: a quantitative method for the evaluation of treatment effect in n=1 studies
31. WS16.5 Website based educational program on cystic fibrosis (CF) for community physicians
32. 223 Infertility among women with cystic fibrosis: prevalence and risk factors
33. WS20.3 Acquired CFTR dysfunction in patients with primary ciliary dyskinesia (PCD)?
34. WS04.5 Vitamin D influence on respiratory exacerbations and hospitalizations in cystic fibrosis patients
35. ePS06.7 Factors associated with failure to eradicate first or newly acquired Pseudomonas aeruginosa in patients with CF
36. 300 Prevalence and characteristics of attention deficit hyperactivity disorder (ADHD) in patients with cystic fibrosis (CF)
37. 297 Arab cystic fibrosis patients in Israel
38. 147 Causes of failure to eradicate Pseudomonas aeruginosa in patients with CF
39. 222 Successful administration of continuous intravenous β-lactam therapy for allergic CF patients failing standard antibiotic desensitization
40. Fungal infection and ABPA in CF
41. Clinical presentation, course and outcome of community acquired complicated pneumonia in Jerusalem 2000–2010
42. What's new in the diagnosis of CF?
43. Comparison of disease expression between patients with primary ciliary dyskinesia (PCD) and patients with CF and pancreatic sufficiency (CF-PS) and insufficiency (CF-PI)
44. Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
45. Building a CF Center in Gaza – a bridge over troubled water
46. Propranolol in the treatment of subglottic hemangioma
47. Intravenous Monthly High-Dose Pulse Methylprednisolone vs Oral Prednisone for Therapy of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis.
48. Concomitant cystic fibrosis and coeliac disease: reminder of an important clinical lesson
49. Intravenous methylprednisolone pulse therapy vs. oral prednisone for allergic bronchopulmonary aspergillosis (ABPA) in CF
50. 374 18FDG-PET/CT in CF: correlation with both inflammatory markers and FEV1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.